Context Therapeutics CNTX
NASDAQ CNTX
$0.17 +0.00 (+0.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Context Therapeutics (CNTX) EBITDA Margin (2021 - 2026)

Updated

Context Therapeutics (CNTX) reported EBITDA Margin of -2398.18% for Q3 2026, down 1126.08 percentage points from -1272.10% a year earlier but up 1175.30 percentage points from the prior quarter.

Analysis

Context Therapeutics (CNTX) EBITDA Margin (2021 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Context Therapeutics' EBITDA Margin came in at -2358.20%, down 1533.27 percentage points year-over-year; for FY2025, it came in at -1174.66%, down 239.94 percentage points from FY2024.

  • EBITDA Margin has a three-year change of +1634.19 percentage points (FY2022 to FY2025).
  • By year, EBITDA Margin came in at -934.72% in FY2024 (+1218.30 pp), -2153.02% in FY2023 (+655.83 pp) and -2808.85% in FY2022.
  • Five-year quarterly EBITDA Margin spans a low of -981556.83% in Q4 2021 and a high of -367.31% in Q2 2024.
  • Year over year, EBITDA Margin has now declined in each of the last four quarters, with an average year-over-year change of -290.80 percentage points over the last eight quarters.
  • The high point for year-over-year EBITDA Margin in five years was Q4 2022 (a gain of 980373.66 percentage points); the low point was Q2 2026 (a drop of 2494.19 percentage points).
  • Per Business Quant data, the three quarters before Q3 2026 came in at -3573.48% (Q2 2026), -1795.50% (Q1 2026) and -2022.11% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -883.96%
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 36.69%
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 32.68%
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 46.88%
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 40.60%
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 46.62%
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 50.63%
9 Gsk 193.54 Bn 176.38 Bn - -
10 Context Therapeutics 15.24 Mn -182.70 Mn - -2,398.18%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -2,398.18%
Jun 30, 2026 -3,573.48%
Mar 31, 2026 -1,795.50%
Dec 31, 2025 -2,022.11%
Sep 30, 2025 -1,272.10%
Jun 30, 2025 -1,079.29%
Mar 31, 2025 -576.42%
Dec 31, 2024 -446.82%
Sep 30, 2024 -1,503.48%
Jun 30, 2024 -367.31%
Mar 31, 2024 -2,507.98%
Dec 31, 2023 -3,084.13%
Sep 30, 2023 -2,126.91%
Jun 30, 2023 -1,803.49%
Mar 31, 2023 -1,874.14%
Dec 31, 2022 -1,183.16%
Sep 30, 2022 -2,104.03%
Jun 30, 2022 -18,806.02%
Mar 31, 2022 -58,713.54%
Dec 31, 2021 -981,556.83%
API Access

Context Therapeutics EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CNTX&period=max&api_key=YOUR_API_KEY